125. Hereditary diffuse leukoencephalopathy with spheroid Disease details / Clinical trials / Drug dev / DR info /

Clinical trial : 1 / Drugs : 9 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0

Drugs and their primary sponsors and trial info

CALD HR-D (High-Risk, Regimen C)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
CALD HR-D (High-Risk, Regimen D)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
CALD SR-A (Standard-Risk, Regimen A)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
CALD SR-B (Standard-Risk, Regimen B)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
IMD Preparative Regimen
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
Osteopetrosis Haploidentical Only Preparative Regimen
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
Osteopetrosis Only Preparative Regimen
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
Stem Cell Transplantation
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;